TOPO INTERNES: L’anesthésie chez le patient atteint d’obésité

Présenté par Juliette DUGUET et Paul PEIGNET sous la direction du Docteur Nicolas COURTIN sur les spécificités de la prise en charge anesthésiques des patients atteints d’obésité

Présenté en octobre 2025.

Le résumé au format pdf: Anesthésie chez le patient Obèse Anesthésie patient obèse (topo 10_2025)

la présentation disponible au téléchargement : Anesthésie chez le patient Obèse  

Références: [1] World Health Organization. Obésité n.d. https://www.emro.who.int/fr/health-topics/obesity/ (accessed February 2, 2026).

[2] NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 2024;403:1027–50. https://doi.org/10.1016/S0140-6736(23)02750-2.

[3] World Health Organization. WHO European Regional Obesity Report 2022 n.d. https://www.who.int/europe/publications/i/item/9789289057738 (accessed February 2, 2026).

[4] Fontbonne A, Currie A, Tounian P, Picot M-C, Foulatier O, Nedelcu M, et al. Prevalence of Overweight and Obesity in France: The 2020 Obepi-Roche Study by the “Ligue Contre l’Obésité.” J Clin Med 2023;12:925. https://doi.org/10.3390/jcm12030925.

[5] De Jong A, Rollé A, Souche F-R, Yengui O, Verzilli D, Chanques G, et al. How can I manage anaesthesia in obese patients? Anaesth Crit Care Pain Med 2020;39:229–38. https://doi.org/10.1016/j.accpm.2019.12.009.

[6] Carron M, Safaee Fakhr B, Ieppariello G, Foletto M. Perioperative care of the obese patient. Br J Surg 2020;107:e39–55. https://doi.org/10.1002/bjs.11447.

[7] Bazurro S, Ball L, Pelosi P. Perioperative management of obese patient. Curr Opin Crit Care 2018;24:560–7. https://doi.org/10.1097/MCC.0000000000000555.

[8] Duprée A, El Gammal AT, Wolter S, Urbanek S, Sauer N, Mann O, et al. Perioperative Short-Term Outcome in Super-Super-Obese Patients Undergoing Bariatric Surgery. Obes Surg 2018;28:1895–901. https://doi.org/10.1007/s11695-018-3118-y.

[9] Pensier J, Monet C, Jaber S, De Jong A. Prise en charge anesthésique du patient adulte avec obésité – EMC Anesthésie-Réanimation -Volume 45, Numéro 2, Pages 1-12. 2025. https://www.clinicalkey.fr/#!/content/emc/51-s2.0-S0246028924484156?scrollTo=%23hl0000397 (accessed February 2, 2026).

[10] Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013;177:1006–14. https://doi.org/10.1093/aje/kws342.

[11] Tishler PV, Larkin EK, Schluchter MD, Redline S. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 2003;289:2230–7. https://doi.org/10.1001/jama.289.17.2230.

[12] Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015–21. https://doi.org/10.1001/jama.284.23.3015.

[13] Messineo L, Bakker JP, Cronin J, Yee J, White DP. Obstructive sleep apnea and obesity: A review of epidemiology, pathophysiology and the effect of weight-loss treatments. Sleep Medicine Reviews 2024;78:101996. https://doi.org/10.1016/j.smrv.2024.101996.

[14] Ravesloot MJL, van Maanen JP, Hilgevoord A a. J, van Wagensveld BA, de Vries N. Obstructive sleep apnea is underrecognized and underdiagnosed in patients undergoing bariatric surgery. Eur Arch Otorhinolaryngol 2012;269:1865–71. https://doi.org/10.1007/s00405-012-1948-0.

[15] Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine n.d.;13:479–504. https://doi.org/10.5664/jcsm.6506.

[16] Société de Pneumologie de Langue Française, Société Française d’Anesthésie Réanimation, Société Française de Cardiologie, Société Française de Médecine du Travail, Société Française d’ORL, Société de Physiologie, et al. [Recommendations for clinical practice. Obstructive sleep apnea hypopnea syndrome in adults]. Rev Mal Respir 2010;27:806–33. https://doi.org/10.1016/j.rmr.2010.05.011.

[17] Johns MW. A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale. Sleep 1991;14:540–5. https://doi.org/10.1093/sleep/14.6.540.

[18] Chung F, Subramanyam R, Liao P, Sasaki E, Shapiro C, Sun Y. High STOP-Bang score indicates a high probability of obstructive sleep apnoea. British Journal of Anaesthesia 2012;108:768–75. https://doi.org/10.1093/bja/aes022.

[19] Chung F, Yang Y, Liao P. Predictive Performance of the STOP-Bang Score for Identifying Obstructive Sleep Apnea in Obese Patients. OBES SURG 2013;23:2050–7. https://doi.org/10.1007/s11695-013-1006-z.

[20] HAS. Comment prescrire les dispositifs médicaux de traitement du syndrome d’apnées hypopnées obstructives du sommeil chez l’adulte 2014.

[21] Masa JF, Corral J, Alonso ML, Ordax E, Troncoso MF, Gonzalez M, et al. Efficacy of Different Treatment Alternatives for Obesity Hypoventilation Syndrome. Pickwick Study. Am J Respir Crit Care Med 2015;192:86–95. https://doi.org/10.1164/rccm.201410-1900OC.

[22] Balachandran JS, Masa JF, Mokhlesi B. Obesity Hypoventilation Syndrome Epidemiology and Diagnosis. Sleep Med Clin 2014;9:341–7. https://doi.org/10.1016/j.jsmc.2014.05.007.

[23] Nowbar S, Burkart KM, Gonzales R, Fedorowicz A, Gozansky WS, Gaudio JC, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med 2004;116:1–7. https://doi.org/10.1016/j.amjmed.2003.08.022.

[24] Kaw R, Chung F, Pasupuleti V, Mehta J, Gay PC, Hernandez AV. Meta-analysis of the association between obstructive sleep apnoea and postoperative outcome. Br J Anaesth 2012;109:897–906. https://doi.org/10.1093/bja/aes308.

[25] Hai F, Porhomayon J, Vermont L, Frydrych L, Jaoude P, El-Solh AA. Postoperative complications in patients with obstructive sleep apnea: a meta-analysis. J Clin Anesth 2014;26:591–600. https://doi.org/10.1016/j.jclinane.2014.05.010.

[26] Flink BJ, Rivelli SK, Cox EA, White WD, Falcone G, Vail TP, et al. Obstructive sleep apnea and incidence of postoperative delirium after elective knee replacement in the nondemented elderly. Anesthesiology 2012;116:788–96. https://doi.org/10.1097/ALN.0b013e31824b94fc.

[27] Lockhart EM, Willingham MD, Abdallah AB, Helsten DL, Bedair BA, Thomas J, et al. Obstructive sleep apnea screening and postoperative mortality in a large surgical cohort. Sleep Med 2013;14:407–15. https://doi.org/10.1016/j.sleep.2012.10.018.

[28] Mutter TC, Chateau D, Moffatt M, Ramsey C, Roos LL, Kryger M. A matched cohort study of postoperative outcomes in obstructive sleep apnea: could preoperative diagnosis and treatment prevent complications? Anesthesiology 2014;121:707–18. https://doi.org/10.1097/ALN.0000000000000407.

[29] Berezin L, Nagappa M, Poorzargar K, Saripella A, Ariaratnam J, Butris N, et al. The effectiveness of positive airway pressure therapy in reducing postoperative adverse outcomes in surgical patients with obstructive sleep apnea: A systematic review and meta-analysis. J Clin Anesth 2023;84:110993. https://doi.org/10.1016/j.jclinane.2022.110993.

[30] De Jong A, Molinari N, Pouzeratte Y, Verzilli D, Chanques G, Jung B, et al. Difficult intubation in obese patients: incidence, risk factors, and complications in the operating theatre and in intensive care units. Br J Anaesth 2015;114:297–306. https://doi.org/10.1093/bja/aeu373.

[31] Perone F, Spadafora L, Pratesi A, Nicolaio G, Pala B, Franco G, et al. Obesity and cardiovascular disease: Risk assessment, physical activity, and management of complications. International Journal of Cardiology Cardiovascular Risk and Prevention 2024;23:200331. https://doi.org/10.1016/j.ijcrp.2024.200331.

[32] Powell-Wiley TM, Poirier P, Burke LE, Després J-P, Gordon-Larsen P, Lavie CJ, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2021;143:e984–1010. https://doi.org/10.1161/CIR.0000000000000973.

[33] Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42:3227–337. https://doi.org/10.1093/eurheartj/ehab484.

[34] Emerging Risk Factors Collaboration, Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011;377:1085–95. https://doi.org/10.1016/S0140-6736(11)60105-0.

[35] Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity–results of a meta-analysis. Am Heart J 2008;155:310–5. https://doi.org/10.1016/j.ahj.2007.10.004.

[36] Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management. Transl Res 2014;164:345–56. https://doi.org/10.1016/j.trsl.2014.04.010.

[37] Yeghiazarians DY, Jneid DH, Tietjens DJR, Redline S, Dr, Brown DL, et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2021;144:e56–67. https://doi.org/10.1161/CIR.0000000000000988.

[38] Holt A, Bjerre J, Zareini B, Koch H, Tønnesen P, Gislason GH, et al. Sleep Apnea, the Risk of Developing Heart Failure, and Potential Benefits of Continuous Positive Airway Pressure (CPAP) Therapy. J Am Heart Assoc 2018;7:e008684. https://doi.org/10.1161/JAHA.118.008684.

[39] Patel N, Donahue C, Shenoy A, Patel A, El-Sherif N. Obstructive sleep apnea and arrhythmia: A systemic review. Int J Cardiol 2017;228:967–70. https://doi.org/10.1016/j.ijcard.2016.11.137. [40] Kholdani C, Fares WH, Mohsenin V. Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology. Pulm Circ 2015;5:220–7. https://doi.org/10.1086/679995.

[41] Després J-P. Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012;126:1301–13. https://doi.org/10.1161/CIRCULATIONAHA.111.067264.

[42] Peters SAE, Bots SH, Woodward M. Sex Differences in the Association Between Measures of General and Central Adiposity and the Risk of Myocardial Infarction: Results From the UK Biobank. Journal of the American Heart Association 2018;7:e008507. https://doi.org/10.1161/JAHA.117.008507.

[43] Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008;359:2105–20. https://doi.org/10.1056/NEJMoa0801891.

[44] Piché M-E, Poirier P, Lemieux I, Després J-P. Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. Prog Cardiovasc Dis 2018;61:103–13. https://doi.org/10.1016/j.pcad.2018.06.004.

[45] Lavie CJ, De Schutter A, Parto P, Jahangir E, Kokkinos P, Ortega FB, et al. Obesity and Prevalence of Cardiovascular Diseases and Prognosis—The Obesity Paradox Updated. Progress in Cardiovascular Diseases 2016;58:537–47. https://doi.org/10.1016/j.pcad.2016.01.008.

[46] Valentijn TM, Galal W, Tjeertes EKM, Hoeks SE, Verhagen HJ, Stolker RJ. The obesity paradox in the surgical population. Surgeon 2013;11:169–76. https://doi.org/10.1016/j.surge.2013.02.003.

[47] Modig K, Erdefelt A, Mellner C, Cederholm T, Talbäck M, Hedström M. “Obesity Paradox” Holds True for Patients with Hip Fracture: A Registry-Based Cohort Study. J Bone Joint Surg Am 2019;101:888–95. https://doi.org/10.2106/JBJS.18.01249.

[48] Hidvegi R, Puelacher C, Gualandro DM, Lampart A, Lurati Buse G, Hammerer-Lerchner A, et al. Obesity paradox and perioperative myocardial infarction/injury in non-cardiac surgery. Clin Res Cardiol 2020;109:1140–7. https://doi.org/10.1007/s00392-020-01605-0.

[49] McCullough PA, Gallagher MJ, Dejong AT, Sandberg KR, Trivax JE, Alexander D, et al. Cardiorespiratory fitness and short-term complications after bariatric surgery. Chest 2006;130:517–25. https://doi.org/10.1378/chest.130.2.517.

[50] Hennis PJ, Meale PM, Hurst RA, O’Doherty AF, Otto J, Kuper M, et al. Cardiopulmonary exercise testing predicts postoperative outcome in patients undergoing gastric bypass surgery. Br J Anaesth 2012;109:566–71. https://doi.org/10.1093/bja/aes225.

[51] Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC). Eur Heart J 2022;43:3826–924. https://doi.org/10.1093/eurheartj/ehac270.

[52] Poirier P, Alpert MA, Fleisher LA, Thompson PD, Sugerman HJ, Burke LE, et al. Cardiovascular Evaluation and Management of Severely Obese Patients Undergoing Surgery. Circulation 2009;120:86–95. https://doi.org/10.1161/CIRCULATIONAHA.109.192575.

[53] Fellahi J-L, Schweizer R. Évaluation préopératoire du risque cardiaque en chirurgie non cardiaque : six règles raisonnables et pragmatiques en 2024. Anesthésie & Réanimation 2024;10:49–54. https://doi.org/10.1016/j.anrea.2023.12.005.

[54] Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–52. https://doi.org/10.1161/CIRCULATIONAHA.105.169404.

[55] GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med 2017;377:13–27. https://doi.org/10.1056/NEJMoa1614362.

[56] Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–5. https://doi.org/10.1161/CIRCULATIONAHA.109.192644.

[57] Wagenknecht LE, Lawrence JM, Isom S, Jensen ET, Dabelea D, Liese AD, et al. Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002-18: results from the population-based SEARCH for Diabetes in Youth study. Lancet Diabetes Endocrinol 2023;11:242–50. https://doi.org/10.1016/S2213-8587(23)00025-6.

[58] Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity. Endocrine Practice 2016;22:1–203. https://doi.org/10.4158/EP161365.GL.

[59] Blüher M. An overview of obesity-related complications: The epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes. Diabetes, Obesity and Metabolism 2025;27:3–19. https://doi.org/10.1111/dom.16263.

[60] Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, American Heart Association, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433–8. https://doi.org/10.1161/01.CIR.0000111245.75752.C6.

[61] Lakka H-M, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men. JAMA 2002;288:2709–16. https://doi.org/10.1001/jama.288.21.2709.

[62] Sherling DH, Perumareddi P, Hennekens CH. Metabolic Syndrome. Journal of Cardiovascular Pharmacology and Therapeutics 2017. https://doi.org/10.1177/1074248416686187.

[63] Glance LG, Wissler R, Mukamel DB, Li Y, Diachun CAB, Salloum R, et al. Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology 2010;113:859–72. https://doi.org/10.1097/ALN.0b013e3181eff32e.

[64] Echahidi N, Pibarot P, Després J-P, Daigle J-M, Mohty D, Voisine P, et al. Metabolic Syndrome Increases Operative Mortality in Patients Undergoing Coronary Artery Bypass Grafting Surgery. Journal of the American College of Cardiology 2007;50:843–51. https://doi.org/10.1016/j.jacc.2007.04.075.

[65] Nightingale CE, Margarson MP, Shearer E, Redman JW, Lucas DN, Cousins JM, et al. Peri-operative management of the obese surgical patient 2015. Anaesthesia 2015;70:859–76. https://doi.org/10.1111/anae.13101.

[66] Benhamou D, Nicolescu-Cardagi B, Cheisson G, Cosson E. Gestion du patient diabétique en péri-opératoire – La SFAR. Société Française d’Anesthésie et de Réanimation 2018. https://dev.sfar.org/gestion-du-patient-diabetique/ (accessed February 3, 2025).

[67] Frisch A, Chandra P, Smiley D, Peng L, Rizzo M, Gatcliffe C, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care 2010;33:1783–8. https://doi.org/10.2337/dc10-0304.

[68] Ojaimi RE, Cheisson G, Cosson E, Ichai C, Jacqueminet S, Nicolescu-Catargi B, et al. Recent advances in perioperative care of patients using new antihyperglycaemic drugs and devices dedicated to diabetes. Anaesth Crit Care Pain Med 2025;44:101468. https://doi.org/10.1016/j.accpm.2024.101468.

[69] Roust LR, DiBaise JK. Nutrient deficiencies prior to bariatric surgery. Curr Opin Clin Nutr Metab Care 2017;20:138–44. https://doi.org/10.1097/MCO.0000000000000352.

[70] Giustina A, di Filippo L, Facciorusso A, Adler RA, Binkley N, Bollerslev J, et al. Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis. Rev Endocr Metab Disord 2023;24:1011–29. https://doi.org/10.1007/s11154-023-09831-3.

[71] Puzziferri N, Roshek TB, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA 2014;312:934–42. https://doi.org/10.1001/jama.2014.10706.

[72] Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis 2020;16:175–247. https://doi.org/10.1016/j.soard.2019.10.025.

[73] Auge M, Menahem B, Savey V, Lee Bion A, Alves A. Complications lors du suivi à long terme après sleeve gastrectomie et bypass gastrique. Quels messages délivrer aux patients et aux praticiens et pourquoi ? Journal de Chirurgie Viscérale 2022;159:314–25. https://doi.org/10.1016/j.jchirv.2021.12.008.

[74] Steenackers N, Van der Schueren B, Mertens A, Lannoo M, Grauwet T, Augustijns P, et al. Iron deficiency after bariatric surgery: what is the real problem? Proc Nutr Soc 2018;77:445–55. https://doi.org/10.1017/S0029665118000149.

[75] Chang CG, Adams-Huet B, Provost DA. Acute post-gastric reduction surgery (APGARS) neuropathy. Obes Surg 2004;14:182–9. https://doi.org/10.1381/096089204322857537.

[76] Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006;354:2340–8. https://doi.org/10.1056/NEJMoa054391.

[77] Suter M, Dorta G, Giusti V, Calmes JM. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients. Obes Surg 2004;14:959–66. https://doi.org/10.1381/0960892041719581.

[78] Buchholz V, Berkenstadt H, Goitein D, Dickman R, Bernstine H, Rubin M. Gastric emptying is not prolonged in obese patients. Surgery for Obesity and Related Diseases 2013;9:714–7. https://doi.org/10.1016/j.soard.2012.03.008.

[79] Verdich C, Lysgård Madsen J, Toubro S, Buemann B, Holst JJ, Astrup A. Effect of obesity and major weight reduction on gastric emptying. Int J Obes 2000;24:899–905. https://doi.org/10.1038/sj.ijo.0801250.

[80] Maltby JR, Pytka S, Watson NC, Cowan RAM, Fick GH. Drinking 300 mL of clear fluid two hours before surgery has no effect on gastric fluid volume and pH in fasting and non-fasting obese patients. Can J Anaesth 2004;51:111–5. https://doi.org/10.1007/BF03018767.

[81] Bouvet L, Benhamou D. Les règles du jeûne préopératoire. Le Praticien En Anesthésie Réanimation 2008;12:413–21. https://doi.org/10.1016/j.pratan.2008.10.009.

[82] Kocian R, Spahn DR. Bronchial aspiration in patients after weight loss due to gastric banding. Anesth Analg 2005;100:1856–7. https://doi.org/10.1213/01.ANE.0000153498.48933.13.

[83] de Jong JR, van Ramshorst B, Timmer R, Gooszen HG, Smout AJPM. Effect of laparoscopic gastric banding on esophageal motility. Obes Surg 2006;16:52–8. https://doi.org/10.1381/096089206775222005.

[84] Merrouche M, Sabaté J-M, Jouet P, Harnois F, Scaringi S, Coffin B, et al. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients before and after bariatric surgery. Obes Surg 2007;17:894–900. https://doi.org/10.1007/s11695-007-9166-3.

[85] Facchiano E, Scaringi S, Sabate J-M, Merrouche M, Jouet P, Coffin B, et al. Is esophageal dysmotility after laparoscopic adjustable gastric banding reversible? Obes Surg 2007;17:832–5. https://doi.org/10.1007/s11695-007-9127-x.

[86] Peterli R, Wölnerhanssen BK, Peters T, Vetter D, Kröll D, Borbély Y, et al. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial. JAMA 2018;319:255–65. https://doi.org/10.1001/jama.2017.20897.

[87] Berg P, McCallum R. Dumping Syndrome: A Review of the Current Concepts of Pathophysiology, Diagnosis, and Treatment. Dig Dis Sci 2016;61:11–8. https://doi.org/10.1007/s10620-015-3839-x.

[88] Cornell S. A review of GLP-1 receptor agonists in type 2 diabetes: A focus on the mechanism of action of once-weekly agents. J Clin Pharm Ther 2020;45 Suppl 1:17–27. https://doi.org/10.1111/jcpt.13230.

[89] Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC). Eur Heart J 2023;44:4043–140. https://doi.org/10.1093/eurheartj/ehad192.

[90] Darmon P, Bauduceau B, Bordier L, Detournay B, Gautier J-F, Gourdy P, et al. Prise de position de la Société Francophone du Diabète (SFD) sur les stratégies d’utilisation des traitements anti-hyperglycémiants dans le diabète de type 2 – 2023. //www.em-premium.com/data/revues/19572557/v17i8/S1957255723002298/ 2023. https://doi.org/10.1016/j.mmm.2023.10.007.

[91] Alter C. Mise au point traitement du diabète (agonistes récepteurs GLP1) et anesthésie – La SFAR. Société Française d’Anesthésie et de Réanimation 2023. https://dev.sfar.org/mise-au-point-traitement-du-diabete-agonistes-recepteurs-glp1-et-anesthesie/ (accessed March 15, 2025).

[92] American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists n.d. https://www.asahq.org/about-asa/newsroom/news-releases/2023/06/american-society-of-anesthesiologists-consensus-based-guidance-on-preoperative (accessed March 20, 2025).

[93] Silveira SQ, da Silva LM, de Campos Vieira Abib A, de Moura DTH, de Moura EGH, Santos LB, et al. Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy. J Clin Anesth 2023;87:111091. https://doi.org/10.1016/j.jclinane.2023.111091.

[94] Sen S, Potnuru PP, Hernandez N, Goehl C, Praestholm C, Sridhar S, et al. Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia. JAMA Surg 2024;159:660–7. https://doi.org/10.1001/jamasurg.2024.0111.

[95] DeMaria EJ, Murr M, Byrne TK, Blackstone R, Grant JP, Budak A, et al. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. Ann Surg 2007;246:578–82; discussion 583-584. https://doi.org/10.1097/SLA.0b013e318157206e.

[96] Thomas H, Agrawal S. Systematic review of obesity surgery mortality risk score–preoperative risk stratification in bariatric surgery. Obes Surg 2012;22:1135–40. https://doi.org/10.1007/s11695-012-0663-7.

[97] García-García ML, Martín-Lorenzo JG, Lirón-Ruiz R, Torralba-Martínez JA, García-López JA, Aguayo-Albasini JL. Failure of the Obesity Surgery Mortality Risk Score (OS-MRS) to Predict Postoperative Complications After Bariatric Surgery. A Single-Center Series and Systematic Review. Obes Surg 2017;27:1423–9. https://doi.org/10.1007/s11695-016-2506-4.

[98] Ingrande J, Lemmens HJM. Dose adjustment of anaesthetics in the morbidly obese. British Journal of Anaesthesia 2010;105:i16–23. https://doi.org/10.1093/bja/aeq312.

[99] Hebbes CP, Thompson JP. Pharmacokinetics of anaesthetic drugs at extremes of body weight. BJA Education 2018;18:364–70. https://doi.org/10.1016/j.bjae.2018.09.001.

[100] Servin F. Anesthésie du patient obèse – EMC. Endocrinologie – Nutrition, 2020-01-01, Volume 31, Numéro 1, Pages 1-12 Elsevier Masson SAS 2019. https://www.clinicalkey.fr/#!/content/emc/51-s2.0-S1155194119848126?scrollTo=%23bib0080 (accessed October 19, 2025).

[101] Cheymol G. Effects of Obesity on Pharmacokinetics. Clin Pharmacokinet 2000;39:215–31. https://doi.org/10.2165/00003088-200039030-00004.

[102] Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003;112:1785–8. https://doi.org/10.1172/JCI20514.

[103] Rose DK, Cohen MM, Wigglesworth DF, DeBoer DP. Critical respiratory events in the postanesthesia care unit. Patient, surgical, and anesthetic factors. Anesthesiology 1994;81:410–8. https://doi.org/10.1097/00000542-199408000-00020.

[104] Servin F, Farinotti R, Haberer JP, Desmonts JM. Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. Anesthesiology 1993;78:657–65. https://doi.org/10.1097/00000542-199304000-00008.

[105] Brill MJE, van Rongen A, Houwink API, Burggraaf J, van Ramshorst B, Wiezer RJ, et al. Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers. Clin Pharmacokinet 2014;53:931–41. https://doi.org/10.1007/s40262-014-0166-x.

[106] Kilpatrick GJ, McIntyre MS, Cox RF, Stafford JA, Pacofsky GJ, Lovell GG, et al. CNS 7056: a novel ultra-short-acting Benzodiazepine. Anesthesiology 2007;107:60–6. https://doi.org/10.1097/01.anes.0000267503.85085.c0.

[107] Abcejo AS, Teixera MT. Remimazolam: Patient Safety Considerations of a Novel, Practice-Changing Drug in Perioperative Medicine. Anesthesia Patient Safety Foundation 2023. https://www.apsf.org/article/remimazolam-patient-safety-considerations-of-a-novel-practice-changing-drug-in-perioperative-medicine/ (accessed June 8, 2025).

[108] Kilpatrick GJ. Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent. Front Pharmacol 2021;12:690875. https://doi.org/10.3389/fphar.2021.690875.

[109] Shimamoto Y, Sanuki M, Kurita S, Ueki M, Kuwahara Y, Matsumoto A. Factors affecting prolonged time to extubation in patients given remimazolam. PLoS One 2022;17:e0268568. https://doi.org/10.1371/journal.pone.0268568.

[110] de Jong BT, Eleveld DJ, Mason KP, Struys MMRF. Clinical Pharmacokinetics and Pharmacodynamics of Remimazolam. Clin Pharmacokinet 2025;64:1263–82. https://doi.org/10.1007/s40262-025-01548-7.

[111] Zhang K, Bao Y, Han X, Zhai W, Yang Y, Luo M, et al. Effects of opioid-free propofol or remimazolam balanced anesthesia on hypoxemia incidence in patients with obesity during gastrointestinal endoscopy: A prospective, randomized clinical trial. Front Med (Lausanne) 2023;10:1124743. https://doi.org/10.3389/fmed.2023.1124743.

[112] Chen M, Wang H, Sun J, Zhang T, Niu X, Zhang T, et al. The dose of remimazolam combined with sufentanil for the induction of general anesthesia in obese patients undergoing bariatric surgery: an up-and-down sequential allocation trial. Front Pharmacol 2024;15:1411856. https://doi.org/10.3389/fphar.2024.1411856.

[113] Xiao H, Gu X, Shi X, Yu S, Ji R, Ji F, et al. Effects of Different Body Mass Indexes on the Induction Dose of Remimazolam in Patients Undergoing Gynaecological Day Surgery: A Propensity Score-Matched Study. Drug Des Devel Ther 2025;19:7285–92. https://doi.org/10.2147/DDDT.S542292.

[114] Naeye RL, Roode P. The sizes and numbers of cells in visceral organs in human obesity. Am J Clin Pathol 1970;54:251–3. https://doi.org/10.1093/ajcp/54.2.251.

[115] Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979;67:811–6. https://doi.org/10.1016/0002-9343(79)90740-x.

[116] Salazar DE, Sorge CL, Corcoran GB. Obesity as a risk factor for drug-induced organ injury. VI. Increased hepatic P450 concentration and microsomal ethanol oxidizing activity in the obese overfed rat. Biochem Biophys Res Commun 1988;157:315–20. https://doi.org/10.1016/s0006-291x(88)80049-4.

[117] Abernethy DR, Greenblatt DJ, Divoll M, Shader RI. Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen. J Lab Clin Med 1983;101:873–80.

[118] Stokholm KH, Brøchner-Mortensen J, Hoilund-Carlsen PF. Increased glomerular filtration rate and adrenocortical function in obese women. Int J Obes 1980;4:57–63.

[119] Plaud B, Baillard C, Bourgain J-L, Bouroche G, Desplanque L, Devys J-M, et al. Guidelines on muscle relaxants and reversal in anaesthesia. Anaesth Crit Care Pain Med 2020;39:125–42. https://doi.org/10.1016/j.accpm.2020.01.005.

[120] Leykin Y, Pellis T, Lucca M, Lomangino G, Marzano B, Gullo A. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth Analg 2004;99:1086–9. https://doi.org/10.1213/01.ANE.0000120081.99080.C2.

[121] Varin F, Ducharme J, Théorêt Y, Besner JG, Bevan DR, Donati F. Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium. Clin Pharmacol Ther 1990;48:18–25. https://doi.org/10.1038/clpt.1990.112.

[122] Loupec T, Frasca D, Rousseau N, Faure J-P, Mimoz O, Debaene B. Appropriate dosing of sugammadex to reverse deep rocuronium-induced neuromuscular blockade in morbidly obese patients. Anaesthesia 2016;71:265–72. https://doi.org/10.1111/anae.13344.

[123] Lemmens HJM, Brodsky JB. The dose of succinylcholine in morbid obesity. Anesth Analg 2006;102:438–42. https://doi.org/10.1213/01.ane.0000194876.00551.0e.

[124] Hammoud HA, Aymard G, Lechat P, Boccheciampe N, Riou B, Aubrun F. Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period. Fundam Clin Pharmacol 2011;25:518–27. https://doi.org/10.1111/j.1472-8206.2010.00867.x.

[125] Gepts E, Shafer SL, Camu F, Stanski DR, Woestenborghs R, Van Peer A, et al. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 1995;83:1194–204. https://doi.org/10.1097/00000542-199512000-00010.

[126] Slepchenko G, Simon N, Goubaux B, Levron J-C, Le Moing J-P, Raucoules-Aimé M. Performance of target-controlled sufentanil infusion in obese patients. Anesthesiology 2003;98:65–73. https://doi.org/10.1097/00000542-200301000-00014.

[127] Egan TD, Huizinga B, Gupta SK, Jaarsma RL, Sperry RJ, Yee JB, et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998;89:562–73. https://doi.org/10.1097/00000542-199809000-00004.

[128] Fletcher D, Martinez V. Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis. Br J Anaesth 2014;112:991–1004. https://doi.org/10.1093/bja/aeu137.

[129] Santonocito C, Noto A, Crimi C, Sanfilippo F. Remifentanil-induced postoperative hyperalgesia: current perspectives on mechanisms and therapeutic strategies. Local Reg Anesth 2018;11:15–23. https://doi.org/10.2147/LRA.S143618.

[130] Kim HJ, Choi GJ, Kang H. Comparison of efficacy and safety profiles of perioperative sufentanil and remifentanil: a systematic review and meta-analysis with trial sequential analysis. Systematic Reviews 2025;14:171. https://doi.org/10.1186/s13643-025-02933-w.

[131] Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 1997;86:24–33. https://doi.org/10.1097/00000542-199701000-00005.

[132] Eleveld DJ, Proost JH, Vereecke H, Absalom AR, Olofsen E, Vuyk J, et al. An Allometric Model of Remifentanil Pharmacokinetics and Pharmacodynamics. Anesthesiology 2017;126:1005–18. https://doi.org/10.1097/ALN.0000000000001634.

[133] Kim TK, Obara S, Egan TD, Minto CF, La Colla L, Drover DR, et al. Disposition of Remifentanil in Obesity: A New Pharmacokinetic Model Incorporating the Influence of Body Mass. Anesthesiology 2017;126:1019–32. https://doi.org/10.1097/ALN.0000000000001635.

[134] Ingrande J, Brodsky JB, Lemmens HJM. Lean body weight scalar for the anesthetic induction dose of propofol in morbidly obese subjects. Anesth Analg 2011;113:57–62. https://doi.org/10.1213/ANE.0b013e3181f6d9c0.

[135] Marsh B, White M, Morton N, Kenny GN. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991;67:41–8. https://doi.org/10.1093/bja/67.1.41.

[136] Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998;88:1170–82. https://doi.org/10.1097/00000542-199805000-00006.

[137] Eleveld DJ, Proost JH, Cortínez LI, Absalom AR, Struys MMRF. A General Purpose Pharmacokinetic Model for Propofol. Anesthesia & Analgesia 2014;118:1221. https://doi.org/10.1213/ANE.0000000000000165.

[138] Eleveld DJ, Colin P, Absalom AR, Struys MMRF. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation. Br J Anaesth 2018;120:942–59. https://doi.org/10.1016/j.bja.2018.01.018.

[139] Zoremba M, Dette F, Hunecke T, Eberhart L, Braunecker S, Wulf H. A comparison of desflurane versus propofol: the effects on early postoperative lung function in overweight patients. Anesth Analg 2011;113:63–9. https://doi.org/10.1213/ANE.0b013e3181fdf5d4.

[140] De Baerdemaeker LEC, Struys MMRF, Jacobs S, Den Blauwen NMM, Bossuyt GRPJ, Pattyn P, et al. Optimization of desflurane administration in morbidly obese patients: a comparison with sevoflurane using an “inhalation bolus” technique. Br J Anaesth 2003;91:638–50. https://doi.org/10.1093/bja/aeg236.

[141] McKay RE, Malhotra A, Cakmakkaya OS, Hall KT, McKay WR, Apfel CC. Effect of increased body mass index and anaesthetic duration on recovery of protective airway reflexes after sevoflurane vs desflurane. Br J Anaesth 2010;104:175–82. https://doi.org/10.1093/bja/aep374.

[142] Arain SR, Barth CD, Shankar H, Ebert TJ. Choice of volatile anesthetic for the morbidly obese patient: sevoflurane or desflurane. J Clin Anesth 2005;17:413–9. https://doi.org/10.1016/j.jclinane.2004.12.015.

[143] Pauchard J-C, Hafiani E-M, Bonnet L, Cabelguenne D, Carenco P, Cassier P, et al. Guidelines for reducing the environmental impact of general anaesthesia. Anaesth Crit Care Pain Med 2023;42:101291. https://doi.org/10.1016/j.accpm.2023.101291.

[144] Brodsky JB. Positioning the morbidly obese patient for anesthesia. Obes Surg 2002;12:751–8. https://doi.org/10.1381/096089202320995510.

[145] Casiglia E, Tikhonoff V, Albertini F, Palatini P. Poor Reliability of Wrist Blood Pressure Self-Measurement at Home: A Population-Based Study. Hypertension 2016;68:896–903. https://doi.org/10.1161/HYPERTENSIONAHA.116.07961.

[146] Ueda K, Hussey P. Dynamic Ultrasound-Guided Short-Axis Needle Tip Navigation Technique for Facilitating Cannulation of Peripheral Veins in Obese Patients. Anesth Analg 2017;124:831–3. https://doi.org/10.1213/ANE.0000000000001653.

[147] Bouaziz H, Zetlaoui PJ, Pierre S, Desruennes E, Fritsch N, Jochum D, et al. Guidelines on the use of ultrasound guidance for vascular access. Anaesth Crit Care Pain Med 2015;34:65–9. https://doi.org/10.1016/j.accpm.2015.01.004.

[148] Jones RL, Nzekwu M-MU. The effects of body mass index on lung volumes. Chest 2006;130:827–33. https://doi.org/10.1378/chest.130.3.827.

[149] Bokov P, Delclaux C. [The impact of obesity on respiratory function]. Rev Mal Respir 2019;36:1057–63. https://doi.org/10.1016/j.rmr.2019.07.009.

[150] Saliman JA, Benditt JO, Flum DR, Oelschlager BK, Dellinger EP, Goss CH. Pulmonary function in the morbidly obese. Surg Obes Relat Dis 2008;4:632–9; discussion 639. https://doi.org/10.1016/j.soard.2008.06.010.

[151] Collet F, Mallart A, Bervar JF, Bautin N, Matran R, Pattou F, et al. Physiologic correlates of dyspnea in patients with morbid obesity. Int J Obes (Lond) 2007;31:700–6. https://doi.org/10.1038/sj.ijo.0803460.

[152] Ochs-Balcom HM, Grant BJB, Muti P, Sempos CT, Freudenheim JL, Trevisan M, et al. Pulmonary function and abdominal adiposity in the general population. Chest 2006;129:853–62. https://doi.org/10.1378/chest.129.4.853.

[153] Rubinstein I, Zamel N, DuBarry L, Hoffstein V. Airflow limitation in morbidly obese, nonsmoking men. Ann Intern Med 1990;112:828–32. https://doi.org/10.7326/0003-4819-112-11-828. [154] Pelosi P, Croci M, Ravagnan I, Cerisara M, Vicardi P, Lissoni A, et al. Respiratory system mechanics in sedated, paralyzed, morbidly obese patients. J Appl Physiol (1985) 1997;82:811–8. https://doi.org/10.1152/jappl.1997.82.3.811.

[155] Reinius H, Jonsson L, Gustafsson S, Sundbom M, Duvernoy O, Pelosi P, et al. Prevention of atelectasis in morbidly obese patients during general anesthesia and paralysis: a computerized tomography study. Anesthesiology 2009;111:979–87. https://doi.org/10.1097/ALN.0b013e3181b87edb.

[156] Grieco DL, Anzellotti GM, Russo A, Bongiovanni F, Costantini B, D’Indinosante M, et al. Airway Closure during Surgical Pneumoperitoneum in Obese Patients. Anesthesiology 2019;131:58–73. https://doi.org/10.1097/ALN.0000000000002662.

[157] Damia G, Mascheroni D, Croci M, Tarenzi L. Perioperative changes in functional residual capacity in morbidly obese patients. Br J Anaesth 1988;60:574–8. https://doi.org/10.1093/bja/60.5.574.

[158] Jense HG, Dubin SA, Silverstein PI, O’Leary-Escolas U. Effect of obesity on safe duration of apnea in anesthetized humans. Anesth Analg 1991;72:89–93. https://doi.org/10.1213/00000539-199101000-00016.

[159] Kress JP, Pohlman AS, Alverdy J, Hall JB. The impact of morbid obesity on oxygen cost of breathing (VO(2RESP)) at rest. Am J Respir Crit Care Med 1999;160:883–6. https://doi.org/10.1164/ajrccm.160.3.9902058.

[160] Lin C-K, Lin C-C. Work of breathing and respiratory drive in obesity. Respirology 2012;17:402–11. https://doi.org/10.1111/j.1440-1843.2011.02124.x.

[161] Tang L, Li S, Huang S, Ma H, Wang Z. Desaturation following rapid sequence induction using succinylcholine vs. rocuronium in overweight patients. Acta Anaesthesiol Scand 2011;55:203–8. https://doi.org/10.1111/j.1399-6576.2010.02365.x.

[162] De Jong A, Futier E, Millot A, Coisel Y, Jung B, Chanques G, et al. How to preoxygenate in operative room: healthy subjects and situations “at risk.” Ann Fr Anesth Reanim 2014;33:457–61. https://doi.org/10.1016/j.annfar.2014.08.001.

[163] Langeron O, Bourgain J-L, Francon D, Amour J, Baillard C, Bouroche G, et al. Difficult intubation and extubation in adult anaesthesia. Anaesth Crit Care Pain Med 2018;37:639–51. https://doi.org/10.1016/j.accpm.2018.03.013.

[164] McKechnie A, Iliff HA, Black R, Ahmad I, Chesworth A, Chesworth P, et al. Airway management in patients living with obesity: best practice recommendations from the Society for Obesity and Bariatric Anaesthesia: Endorsed by the All Wales Airway Group, Scottish Airway Group and Difficult Airway Society. Anaesthesia 2025;80:1103–14. https://doi.org/10.1111/anae.16647.

[165] Dixon BJ, Dixon JB, Carden JR, Burn AJ, Schachter LM, Playfair JM, et al. Preoxygenation is more effective in the 25 degrees head-up position than in the supine position in severely obese patients: a randomized controlled study. Anesthesiology 2005;102:1110–5; discussion 5A. https://doi.org/10.1097/00000542-200506000-00009.

[166] Altermatt FR, Muñoz HR, Delfino AE, Cortínez LI. Pre-oxygenation in the obese patient: effects of position on tolerance to apnoea. Br J Anaesth 2005;95:706–9. https://doi.org/10.1093/bja/aei231.

[167] Gander S, Frascarolo P, Suter M, Spahn DR, Magnusson L. Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients. Anesth Analg 2005;100:580–4. https://doi.org/10.1213/01.ANE.0000143339.40385.1B.

[168] Futier E, Constantin J-M, Pelosi P, Chanques G, Massone A, Petit A, et al. Noninvasive ventilation and alveolar recruitment maneuver improve respiratory function during and after intubation of morbidly obese patients: a randomized controlled study. Anesthesiology 2011;114:1354–63. https://doi.org/10.1097/ALN.0b013e31821811ba.

[169] Delay J-M, Sebbane M, Jung B, Nocca D, Verzilli D, Pouzeratte Y, et al. The effectiveness of noninvasive positive pressure ventilation to enhance preoxygenation in morbidly obese patients: a randomized controlled study. Anesth Analg 2008;107:1707–13. https://doi.org/10.1213/ane.0b013e318183909b.

[170] Collet L, Constantin J-M. Techniques de pré-oxygénation : oxygénothérapie à haut débit ou ventilation non invasive. Anesthésie & Réanimation 2025;11:405–10. https://doi.org/10.1016/j.anrea.2025.09.003.

[171] Nay M-A, Fromont L, Eugene A, Marcueyz J-L, Mfam W-S, Baert O, et al. High-flow nasal oxygenation or standard oxygenation for gastrointestinal endoscopy with sedation in patients at risk of hypoxaemia: a multicentre randomised controlled trial (ODEPHI trial). British Journal of Anaesthesia 2021;127:133–42. https://doi.org/10.1016/j.bja.2021.03.020.

[172] Patel A, Nouraei S a. R. Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE): a physiological method of increasing apnoea time in patients with difficult airways. Anaesthesia 2015;70:323–9. https://doi.org/10.1111/anae.12923.

[173] Wong DT, Dallaire A, Singh KP, Madhusudan P, Jackson T, Singh M, et al. High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial. Anesth Analg 2019;129:1130–6. https://doi.org/10.1213/ANE.0000000000003966.

[174] Schutzer-Weissmann J, Wojcikiewicz T, Karmali A, Lukosiute A, Sun R, Kanji R, et al. Apnoeic oxygenation in morbid obesity: a randomised controlled trial comparing facemask and high-flow nasal oxygen delivery. Br J Anaesth 2023;130:103–10. https://doi.org/10.1016/j.bja.2021.12.011.

[175] Vourc’h M, Huard D, Le Penndu M, Deransy R, Surbled M, Malidin M, et al. High-flow oxygen therapy versus facemask preoxygenation in anticipated difficult airway management (PREOPTI-DAM): an open-label, single-centre, randomised controlled phase 3 trial. EClinicalMedicine 2023;60:101998. https://doi.org/10.1016/j.eclinm.2023.101998.

[176] Jaber S, De Jong A, Schaefer MS, Zhang J, Ma X, Hao X, et al. Preoxygenation with standard facemask combining apnoeic oxygenation using high flow nasal cannula versuss standard facemask alone in patients with and without obesity: the OPTIMASK international study. Ann Intensive Care 2023;13:26. https://doi.org/10.1186/s13613-023-01124-x.

[177] Vourc’h M, Baud G, Feuillet F, Blanchard C, Mirallie E, Guitton C, et al. High-flow Nasal Cannulae Versus Non-invasive Ventilation for Preoxygenation of Obese Patients: The PREOPTIPOP Randomized Trial. EClinicalMedicine 2019;13:112–9. https://doi.org/10.1016/j.eclinm.2019.05.014.

[178] Russotto V, Laffey JG, Tassistro E, Myatra SN, Rezoagli E, Foti G, et al. Peri-intubation complications in critically ill obese patients: a secondary analysis of the international INTUBE cohort. Crit Care 2025;29:192. https://doi.org/10.1186/s13054-025-05419-2.

[179] Aoragh A, Pastijn E, Cadiere GB, Kapessidou Y. Rapid sequence induction versus routine induction in obese patients scheduled for bariatric surgery: 19AP3-6. European Journal of Anaesthesiology | EJA 2013;30:257.

[180] Kheterpal S, Martin L, Shanks AM, Tremper KK. Prediction and outcomes of impossible mask ventilation: a review of 50,000 anesthetics. Anesthesiology 2009;110:891–7. https://doi.org/10.1097/ALN.0b013e31819b5b87.

[181] Harper NJN, Cook TM, Garcez T, Farmer L, Floss K, Marinho S, et al. Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6). Br J Anaesth 2018;121:159–71. https://doi.org/10.1016/j.bja.2018.04.014.

[182] Tacquard C, Serrier J, Viville S, Chiriac A-M, Franchina S, Gouel-Cheron A, et al. Epidemiology of perioperative anaphylaxis in France in 2017-2018: the 11th GERAP survey. Br J Anaesth 2024;132:1230–7. https://doi.org/10.1016/j.bja.2024.01.044.

[183] Znaïdi S, Deransy R, Asehnoune K, Le Penndu M, Rozec B, Jumel G, et al. Intubation of obese patients in the operating room with or without bag-mask ventilation: study protocol for a randomized multicenter trial (VENT OR NOT). Trials 2025;26:492. https://doi.org/10.1186/s13063-025-09114-z.

[184] Muñoz-Martínez T, Garrido-Santos I, Arévalo-Cerón R, Rojas-Viguera L, Cantera-Fernández T, Pérez-González R, et al. [Contraindications to succinylcholine in the intensive care unit. A prevalence study]. Med Intensiva 2015;39:90–6. https://doi.org/10.1016/j.medin.2014.07.002.

[185] Tran DTT, Newton EK, Mount VAH, Lee JS, Wells GA, Perry JJ. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev 2015;2015:CD002788. https://doi.org/10.1002/14651858.CD002788.pub3.

[186] de Almeida MCS, Pederneiras SG, Chiaroni S, de Souza L, Locks G de F. [Evaluation of tracheal intubation conditions in morbidly obese patients: a comparison of succinylcholine and rocuronium]. Rev Esp Anestesiol Reanim 2009;56:3–8. https://doi.org/10.1016/s0034-9356(09)70313-5.

[187] Sørensen MK, Bretlau C, Gätke MR, Sørensen AM, Rasmussen LS. Rapid sequence induction and intubation with rocuronium-sugammadex compared with succinylcholine: a randomized trial. Br J Anaesth 2012;108:682–9. https://doi.org/10.1093/bja/aer503.

[188] Lee C, Jahr JS, Candiotti KA, Warriner B, Zornow MH, Naguib M. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine. Anesthesiology 2009;110:1020–5. https://doi.org/10.1097/ALN.0b013e31819dabb0.

[189] Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V, et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology 2007;106:935–43. https://doi.org/10.1097/01.anes.0000265152.78943.74.

[190] Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, et al. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology 2008;109:188–97. https://doi.org/10.1097/ALN.0b013e31817f5bc7.

[191] de Boer HD, Driessen JJ, Marcus MAE, Kerkkamp H, Heeringa M, Klimek M. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology 2007;107:239–44. https://doi.org/10.1097/01.anes.0000270722.95764.37.

[192] Bouvet L, Stoian A, Rimmelé T, Allaouchiche B, Chassard D, Boselli E. Optimal remifentanil dosage for providing excellent intubating conditions when co-administered with a single standard dose of propofol. Anaesthesia 2009;64:719–26. https://doi.org/10.1111/j.1365-2044.2009.05916.x.

[193] Erhan E, Ugur G, Alper I, Gunusen I, Ozyar B. Tracheal intubation without muscle relaxants: remifentanil or alfentanil in combination with propofol. Eur J Anaesthesiol 2003;20:37–43. https://doi.org/10.1017/s0265021503000073.

[194] McNeil IA, Culbert B, Russell I. Comparison of intubating conditions following propofol and succinylcholine with propofol and remifentanil 2 micrograms kg-1 or 4 micrograms kg-1. Br J Anaesth 2000;85:623–5. https://doi.org/10.1093/bja/85.4.623.

[195] Grillot N, Lebuffe G, Huet O, Lasocki S, Pichon X, Oudot M, et al. Effect of Remifentanil vs Neuromuscular Blockers During Rapid Sequence Intubation on Successful Intubation Without Major Complications Among Patients at Risk of Aspiration: A Randomized Clinical Trial. JAMA 2023;329:28–38. https://doi.org/10.1001/jama.2022.23550.

[196] Goudy P, Denis-Bonnin A, Thalamas C, Rousseau V, Migueres I, Faure G, et al. Quality of intubation using remifentanil in obese patients (OBEREM): a randomised, double-blind pilot trial. Anaesth Crit Care Pain Med 2025:101673. https://doi.org/10.1016/j.accpm.2025.101673.

[197] Ndoko SK, Amathieu R, Tual L, Polliand C, Kamoun W, El Housseini L, et al. Tracheal intubation of morbidly obese patients: a randomized trial comparing performance of Macintosh and Airtraq laryngoscopes. Br J Anaesth 2008;100:263–8. https://doi.org/10.1093/bja/aem346.

[198] Andersen LH, Rovsing L, Olsen KS. GlideScope videolaryngoscope vs. Macintosh direct laryngoscope for intubation of morbidly obese patients: a randomized trial. Acta Anaesthesiol Scand 2011;55:1090–7. https://doi.org/10.1111/j.1399-6576.2011.02498.x.

[199] Ranieri D, Filho SM, Batista S, do Nascimento P. Comparison of Macintosh and AirtraqTM laryngoscopes in obese patients placed in the ramped position. Anaesthesia 2012;67:980–5. https://doi.org/10.1111/j.1365-2044.2012.07200.x.

[200] Hoshijima H, Denawa Y, Tominaga A, Nakamura C, Shiga T, Nagasaka H. Videolaryngoscope versus Macintosh laryngoscope for tracheal intubation in adults with obesity: A systematic review and meta-analysis. J Clin Anesth 2018;44:69–75. https://doi.org/10.1016/j.jclinane.2017.11.008.

[201] De Jong A, Sfara T, Pouzeratte Y, Pensier J, Rolle A, Chanques G, et al. Videolaryngoscopy as a first-intention technique for tracheal intubation in unselected surgical patients: a before and after observational study. Br J Anaesth 2022;129:624–34. https://doi.org/10.1016/j.bja.2022.05.030.

[202] Hansel J, Rogers AM, Lewis SR, Cook TM, Smith AF. Videolaryngoscopy versus direct laryngoscopy for adults undergoing tracheal intubation: a Cochrane systematic review and meta-analysis update. Br J Anaesth 2022;129:612–23. https://doi.org/10.1016/j.bja.2022.05.027.

[203] Goh ZJ, Ang A, Ang S-XN, See S, Zhang J, Venkatesan K, et al. Videolaryngoscopy vs. direct laryngoscopy in class 2 and 3 obesity: a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials. Anaesthesia 2025;80:684–93. https://doi.org/10.1111/anae.16578.

[204] Gómez-Ríos MÁ, Van Zundert AAJ, McNarry AF, Law JA, Higgs A, De Jong A, et al. Guidelines on strategies for the universal implementation of videolaryngoscopy. Eur J Anaesthesiol 2025;42:872–88. https://doi.org/10.1097/EJA.0000000000002210.

[205] Collins JS, Lemmens HJM, Brodsky JB, Brock-Utne JG, Levitan RM. Laryngoscopy and morbid obesity: a comparison of the “sniff” and “ramped” positions. Obes Surg 2004;14:1171–5. https://doi.org/10.1381/0960892042386869.

[206] Boyce JR, Ness T, Castroman P, Gleysteen JJ. A preliminary study of the optimal anesthesia positioning for the morbidly obese patient. Obes Surg 2003;13:4–9. https://doi.org/10.1381/096089203321136511.

[207] Lee S, Jang E-A, Hong M, Bae H-B, Kim J. Ramped versus sniffing position in the videolaryngoscopy-guided tracheal intubation of morbidly obese patients: a prospective randomized study. Korean J Anesthesiol 2023;76:47–55. https://doi.org/10.4097/kja.22268.

[208] Futier E, Constantin J-M, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, et al. A Trial of Intraoperative Low-Tidal-Volume Ventilation in Abdominal Surgery. New England Journal of Medicine 2013;369:428–37. https://doi.org/10.1056/NEJMoa1301082.

[209] De Jong A, Chanques G, Jaber S. Mechanical ventilation in obese ICU patients: from intubation to extubation. Crit Care 2017;21:63. https://doi.org/10.1186/s13054-017-1641-1.

[210] Young CC, Harris EM, Vacchiano C, Bodnar S, Bukowy B, Elliott RRD, et al. Lung-protective ventilation for the surgical patient: international expert panel-based consensus recommendations. Br J Anaesth 2019;123:898–913. https://doi.org/10.1016/j.bja.2019.08.017.

[211] Talab HF, Zabani IA, Abdelrahman HS, Bukhari WL, Mamoun I, Ashour MA, et al. Intraoperative ventilatory strategies for prevention of pulmonary atelectasis in obese patients undergoing laparoscopic bariatric surgery. Anesth Analg 2009;109:1511–6. https://doi.org/10.1213/ANE.0b013e3181ba7945.

[212] Writing Committee for the PROBESE Collaborative Group of the PROtective VEntilation Network (PROVEnet) for the Clinical Trial Network of the European Society of Anaesthesiology, Bluth T, Serpa Neto A, Schultz MJ, Pelosi P, Gama de Abreu M, et al. Effect of Intraoperative High Positive End-Expiratory Pressure (PEEP) With Recruitment Maneuvers vs Low PEEP on Postoperative Pulmonary Complications in Obese Patients: A Randomized Clinical Trial. JAMA 2019;321:2292–305. https://doi.org/10.1001/jama.2019.7505.

[213] Godet T, Futier E. Setting Positive End-Expiratory Pressure in Mechanically Ventilated Patients Undergoing Surgery. JAMA 2019;321:2285–7. https://doi.org/10.1001/jama.2019.7540.

[214] Pereira SM, Tucci MR, Morais CCA, Simões CM, Tonelotto BFF, Pompeo MS, et al. Individual Positive End-expiratory Pressure Settings Optimize Intraoperative Mechanical Ventilation and Reduce Postoperative Atelectasis. Anesthesiology 2018;129:1070. https://doi.org/10.1097/ALN.0000000000002435.

[215] Hemmes SNT, Pelosi P, Schultz MJ, PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthesiology. High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet 2014;384:495–503. https://doi.org/10.1016/S0140-6736(14)60416-5.

[216] Tharp WG, Murphy S, Breidenstein MW, Love C, Booms A, Rafferty MN, et al. Body Habitus and Dynamic Surgical Conditions Independently Impair Pulmonary Mechanics during Robotic-assisted Laparoscopic Surgery. Anesthesiology 2020;133:750–63. https://doi.org/10.1097/ALN.0000000000003442.

[217] Costa Souza GM, Santos GM, Zimpel SA, Melnik T. Intraoperative ventilation strategies for obese patients undergoing bariatric surgery: systematic review and meta-analysis. BMC Anesthesiol 2020;20:36. https://doi.org/10.1186/s12871-020-0936-y.

[218] Aldenkortt M, Lysakowski C, Elia N, Brochard L, Tramèr MR. Ventilation strategies in obese patients undergoing surgery: a quantitative systematic review and meta-analysis. Br J Anaesth 2012;109:493–502. https://doi.org/10.1093/bja/aes338.

[219] Ingrande J, Brodsky JB, Lemmens HJ. Regional anesthesia and obesity. Curr Opin Anaesthesiol 2009;22:683–6. https://doi.org/10.1097/ACO.0b013e32832eb7bd.

[220] De Cassai A, Paganini G, Pettenuzzo T, Zarantonello F, Boscolo A, Tulgar S, et al. Single-Shot Regional Anesthesia for Bariatric Surgery: a Systematic Review and Network Meta-Analysis. Obes Surg 2023;33:2687–94. https://doi.org/10.1007/s11695-023-06737-6.

[221] Fuzier R. [Regional anaesthesia in obese patient]. Ann Fr Anesth Reanim 2012;31:228–31. https://doi.org/10.1016/j.annfar.2011.08.005.

[222] Nielsen KC, Guller U, Steele SM, Klein SM, Greengrass RA, Pietrobon R. Influence of obesity on surgical regional anesthesia in the ambulatory setting: an analysis of 9,038 blocks. Anesthesiology 2005;102:181–7. https://doi.org/10.1097/00000542-200501000-00027.

[223] Vricella LK, Louis JM, Mercer BM, Bolden N. Anesthesia complications during scheduled cesarean delivery for morbidly obese women. Am J Obstet Gynecol 2010;203:276.e1-5. https://doi.org/10.1016/j.ajog.2010.06.022.

[224] Tonidandel A, Booth J, D’Angelo R, Harris L, Tonidandel S. Anesthetic and obstetric outcomes in morbidly obese parturients: a 20-year follow-up retrospective cohort study. Int J Obstet Anesth 2014;23:357–64. https://doi.org/10.1016/j.ijoa.2014.05.004.

[225] Sahin T, Balaban O, Sahin L, Solak M, Toker K. A randomized controlled trial of preinsertion ultrasound guidance for spinal anaesthesia in pregnancy: outcomes among obese and lean parturients: ultrasound for spinal anesthesia in pregnancy. J Anesth 2014;28:413–9. https://doi.org/10.1007/s00540-013-1726-1.

[226] Ekinci M, Alici HA, Ahiskalioglu A, Ince I, Aksoy M, Celik EC, et al. The use of ultrasound in planned cesarean delivery under spinal anesthesia for patients having nonprominent anatomic landmarks. J Clin Anesth 2017;37:82–5. https://doi.org/10.1016/j.jclinane.2016.10.014.

[227] Young B, Onwochei D, Desai N. Conventional landmark palpation vs. preprocedural ultrasound for neuraxial analgesia and anaesthesia in obstetrics – a systematic review and meta-analysis with trial sequential analyses. Anaesthesia 2021;76:818–31. https://doi.org/10.1111/anae.15255.

[228] Jiang L, Zhang F, Wei N, Lv J, Chen W, Dai Z. Could preprocedural ultrasound increase the first-pass success rate of neuraxial anesthesia in obstetrics? A systematic review and meta-analysis of randomized controlled trials. J Anesth 2020;34:434–44. https://doi.org/10.1007/s00540-020-02750-6.

[229] Boselli E, Hopkins P, Lamperti M, Estèbe J-P, Fuzier R, Biasucci DG, et al. European Society of Anaesthesiology and Intensive Care Guidelines on peri-operative use of ultrasound for regional anaesthesia (PERSEUS regional anesthesia): Peripheral nerves blocks and neuraxial anaesthesia. Eur J Anaesthesiol 2021;38:219–50. https://doi.org/10.1097/EJA.0000000000001383.

[230] Keita-Meyer H, Bonnet M-P, Morau E. Prise en charge de la douleur de l’accouchement : analgésie périmédullaire et alternatives médicamenteuses – Recommandations Formalisées d’Experts (RFE) – SFAR/CARO. Société Française d’Anesthésie et de Réanimation 2025. https://sfar.org/prise-en-charge-de-la-douleur-de-laccouchement-analgesie-perimedullaire-et-alternatives-medicamenteuses/ (accessed January 20, 2026).

[231] Saranteas T. Limitations in ultrasound imaging techniques in anesthesia: obesity and muscle atrophy? Anesth Analg 2009;109:993–4. https://doi.org/10.1213/ane.0b013e3181ae09a4.

[232] Taylor A, McLeod G. Basic pharmacology of local anaesthetics. BJA Educ 2020;20:34–41. https://doi.org/10.1016/j.bjae.2019.10.002.

[233] Hogan QH, Prost R, Kulier A, Taylor ML, Liu S, Mark L. Magnetic resonance imaging of cerebrospinal fluid volume and the influence of body habitus and abdominal pressure. Anesthesiology 1996;84:1341–9. https://doi.org/10.1097/00000542-199606000-00010.

[234] Patel SD, Habib AS. Anaesthesia for the parturient with obesity. BJA Educ 2021;21:180–6. https://doi.org/10.1016/j.bjae.2020.12.007.

[235] Ngaka TC, Coetzee JF, Dyer RA. The Influence of Body Mass Index on Sensorimotor Block and Vasopressor Requirement During Spinal Anesthesia for Elective Cesarean Delivery. Anesth Analg 2016;123:1527–34. https://doi.org/10.1213/ANE.0000000000001568.

[236] Lamon AM, Einhorn LM, Cooter M, Habib AS. The impact of body mass index on the risk of high spinal block in parturients undergoing cesarean delivery: a retrospective cohort study. J Anesth 2017;31:552–8. https://doi.org/10.1007/s00540-017-2352-0.

[237] Al-Nasser B. Review of interscalene block for postoperative analgesia after shoulder surgery in obese patients. Acta Anaesthesiol Taiwan 2012;50:29–34. https://doi.org/10.1016/j.aat.2012.02.001.

[238] Melton MS, Monroe HE, Qi W, Lewis SL, Nielsen KC, Klein SM. Effect of Interscalene Brachial Plexus Block on the Pulmonary Function of Obese Patients: A Prospective, Observational Cohort Study. Anesth Analg 2017;125:313–9. https://doi.org/10.1213/ANE.0000000000002180.

[239] Marty P, Ferré F, Basset B, Marquis C, Bataille B, Chaubard M, et al. Diaphragmatic paralysis in obese patients in arthroscopic shoulder surgery: consequences and causes. J Anesth 2018;32:333–40. https://doi.org/10.1007/s00540-018-2477-9.

[240] Bomberg H, Albert N, Schmitt K, Gräber S, Kessler P, Steinfeldt T, et al. Obesity in regional anesthesia–a risk factor for peripheral catheter-related infections. Acta Anaesthesiol Scand 2015;59:1038–48. https://doi.org/10.1111/aas.12548.

[241] Garnier M, Gauzit R, Dahyot-Fizelier C. Antibioprophylaxie en chirurgie et médecine interventionnelle – Recommandations formalisées d’expert SFAR-SPILF. Société Française d’Anesthésie et de Réanimation 2024. https://sfar.org/antibioprophylaxie-en-chirurgie-et-medecine-interventionnelle/ (accessed October 22, 2025).

[242] Märtson A-G, Barber KE, Crass RL, Hites M, Kloft C, Kuti JL, et al. The pharmacokinetics of antibiotics in patients with obesity: a systematic review and consensus guidelines for dose adjustments. Lancet Infect Dis 2025;25:e504–15. https://doi.org/10.1016/S1473-3099(25)00155-0.

[243] van Kralingen S, Taks M, Diepstraten J, van de Garde EM, van Dongen EP, Wiezer MJ, et al. Pharmacokinetics and protein binding of cefazolin in morbidly obese patients. Eur J Clin Pharmacol 2011;67:985–92. https://doi.org/10.1007/s00228-011-1048-x.

[244] Grupper M, Kuti JL, Swank ML, Maggio L, Hughes BL, Nicolau DP. Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery. J Clin Pharmacol 2017;57:712–9. https://doi.org/10.1002/jcph.851.

[245] Hodiamont CJ, van den Broek AK, de Vroom SL, Prins JM, Mathôt RAA, van Hest RM. Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review. Clin Pharmacokinet 2022;61:1075–94. https://doi.org/10.1007/s40262-022-01143-0.

[246] Unger NR, Stein BJ. Effectiveness of pre-operative cefazolin in obese patients. Surg Infect (Larchmt) 2014;15:412–6. https://doi.org/10.1089/sur.2012.167.

[247] Hussain Z, Curtain C, Mirkazemi C, Gadd K, Peterson GM, Zaidi STR. Prophylactic Cefazolin Dosing and Surgical Site Infections: Does the Dose Matter in Obese Patients? Obes Surg 2019;29:159–65. https://doi.org/10.1007/s11695-018-3497-0.

[248] Peppard WJ, Eberle DG, Kugler NW, Mabrey DM, Weigelt JA. Association between Pre-Operative Cefazolin Dose and Surgical Site Infection in Obese Patients. Surg Infect (Larchmt) 2017;18:485–90. https://doi.org/10.1089/sur.2016.182.

[249] Banoub M, Curless MS, Smith JM, Jarrell AS, Cosgrove SE, Rock C, et al. Higher versus Lower Dose of Cefotetan or Cefoxitin for Surgical Prophylaxis in Patients Weighing One Hundred Twenty Kilograms or More. Surg Infect (Larchmt) 2018;19:504–9. https://doi.org/10.1089/sur.2017.296.

[250] Smit C, van Schip AM, van Dongen EPA, Brüggemann RJM, Becker ML, Knibbe CAJ. Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)function. J Antimicrob Chemother 2020;75:3286–92. https://doi.org/10.1093/jac/dkaa312.

[251] Smith MJ, Gonzalez D, Goldman JL, Yogev R, Sullivan JE, Reed MD, et al. Pharmacokinetics of Clindamycin in Obese and Nonobese Children. Antimicrob Agents Chemother 2017;61:e02014-16. https://doi.org/10.1128/AAC.02014-16.

[252] Cox KK, Alexander B, Livorsi DJ, Heintz BH. Clinical outcomes in patients hospitalized with cellulitis treated with oral clindamycin and trimethoprim/sulfamethoxazole: The role of weight-based dosing. J Infect 2017;75:486–92. https://doi.org/10.1016/j.jinf.2017.09.009.

[253] Smit C, Wasmann RE, Goulooze SC, Wiezer MJ, van Dongen EPA, Mouton JW, et al. Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals. Br J Clin Pharmacol 2020;86:303–17. https://doi.org/10.1111/bcp.14144.

[254] Morrill HJ, Caffrey AR, Noh E, LaPlante KL. Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients. Pharmacotherapy 2015;35:869–75. https://doi.org/10.1002/phar.1625.

[255] Martel TJ, Jamil RT, Afzal M. Vancomycin Infusion Reaction. StatPearls, Treasure Island (FL): StatPearls Publishing; 2025.

[256] Ammar H, Rolland S, Jouffroy R, Dubert M, Le Beller C, Podglajen I, et al. Frequency and factors associated with infusion-related local complications of vancomycin on peripheral venous catheters. J Antimicrob Chemother 2023;78:1050–4. https://doi.org/10.1093/jac/dkad044.

[257] Renz CL, Thurn JD, Finn HA, Lynch JP, Moss J. Antihistamine prophylaxis permits rapid vancomycin infusion. Crit Care Med 1999;27:1732–7. https://doi.org/10.1097/00003246-199909000-00006.

[258] Lemaitre F. Adaptation de posologie des antibiotiques chez le patient en surpoids. La Lettre du Pharmacologue N° 1-2 2020. https://www.edimark.fr/revues/la-lettre-du-pharmacologue/n-1-2-juin-2020-copy-copy/adaptation-de-posologie-desantibiotiques-chezlepatient-ensurpoids (accessed October 23, 2025).

[259] Castro-Balado A, Varela-Rey I, Mejuto B, Mondelo-García C, Zarra-Ferro I, Rodríguez-Jato T, et al. Updated antimicrobial dosing recommendations for obese patients. Antimicrob Agents Chemother 2024;68:e0171923. https://doi.org/10.1128/aac.01719-23.

[260] Mellon G, Hammas K, Burdet C, Duval X, Carette C, El-Helali N, et al. Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav. J Antimicrob Chemother 2020;75:3611–8. https://doi.org/10.1093/jac/dkaa368.

[261] Gatti M, Cojutti PG, Pea F. Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis. Crit Care 2024;28:123. https://doi.org/10.1186/s13054-024-04911-5.

[262] Cheatham SC, Fleming MR, Healy DP, Chung CEK, Shea KM, Humphrey ML, et al. Steady-state pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese patients. Int J Antimicrob Agents 2013;41:52–6. https://doi.org/10.1016/j.ijantimicag.2012.09.004.

[263] Sturm AW, Allen N, Rafferty KD, Fish DN, Toschlog E, Newell M, et al. Pharmacokinetic analysis of piperacillin administered with tazobactam in critically ill, morbidly obese surgical patients. Pharmacotherapy 2014;34:28–35. https://doi.org/10.1002/phar.1324.

[264] Jung B, Mahul M, Breilh D, Legeron R, Signe J, Jean-Pierre H, et al. Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and the Risk of Under- and Overdosing. Crit Care Med 2017;45:e470–8. https://doi.org/10.1097/CCM.0000000000002287.

[265] Barber KE, Loper JT, Morrison AR, Stover KR, Wagner JL. Impact of Obesity on Ceftriaxone Efficacy. Diseases 2020;8:27. https://doi.org/10.3390/diseases8030027.

[266] Roger C, Louart B. Beta-Lactams Toxicity in the Intensive Care Unit: An Underestimated Collateral Damage? Microorganisms 2021;9:1505. https://doi.org/10.3390/microorganisms9071505.

[267] Simon P, Busse D, Petroff D, Dorn C, Ehmann L, Hochstädt S, et al. Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study. J Clin Med 2020;9:1067. https://doi.org/10.3390/jcm9041067.

[268] Abbott TEF, Fowler AJ, Pelosi P, Gama de Abreu M, Møller AM, Canet J, et al. A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications. Br J Anaesth 2018;120:1066–79. https://doi.org/10.1016/j.bja.2018.02.007.

[269] Neligan PJ, Malhotra G, Fraser M, Williams N, Greenblatt EP, Cereda M, et al. Continuous positive airway pressure via the Boussignac system immediately after extubation improves lung function in morbidly obese patients with obstructive sleep apnea undergoing laparoscopic bariatric surgery. Anesthesiology 2009;110:878–84. https://doi.org/10.1097/ALN.0b013e31819b5d8c.

[270] Gaszynski T, Tokarz A, Piotrowski D, Machala W. Boussignac CPAP in the postoperative period in morbidly obese patients. Obes Surg 2007;17:452–6. https://doi.org/10.1007/s11695-007-9079-1.

[271] Zoremba M, Kalmus G, Begemann D, Eberhart L, Zoremba N, Wulf H, et al. Short term non-invasive ventilation post-surgery improves arterial blood-gases in obese subjects compared to supplemental oxygen delivery – a randomized controlled trial. BMC Anesthesiol 2011;11:10. https://doi.org/10.1186/1471-2253-11-10.

[272] Guimarães J, Pinho D, Nunes CS, Cavaleiro CS, Machado HS. Effect of Boussignac continuous positive airway pressure ventilation on Pao2 and Pao2/Fio2 ratio immediately after extubation in morbidly obese patients undergoing bariatric surgery: a randomized controlled trial. J Clin Anesth 2016;34:562–70. https://doi.org/10.1016/j.jclinane.2016.06.024.

[273] Carron M, Zarantonello F, Tellaroli P, Ori C. Perioperative noninvasive ventilation in obese patients: a qualitative review and meta-analysis. Surg Obes Relat Dis 2016;12:681–91. https://doi.org/10.1016/j.soard.2015.12.013.

[274] Li R, Liu L, Wei K, Zheng X, Zeng J, Chen Q. Effect of noninvasive respiratory support after extubation on postoperative pulmonary complications in obese patients: A systematic review and network meta-analysis. J Clin Anesth 2023;91:111280. https://doi.org/10.1016/j.jclinane.2023.111280.

[275] De Jong A, Bignon A, Stephan F, Godet T, Constantin J-M, Asehnoune K, et al. Effect of non-invasive ventilation after extubation in critically ill patients with obesity in France: a multicentre, unblinded, pragmatic randomised clinical trial. Lancet Respir Med 2023;11:530–9. https://doi.org/10.1016/S2213-2600(22)00529-X.

[276] Sahin M, El H, Akkoç I. Comparison of Mask Oxygen Therapy and High-Flow Oxygen Therapy after Cardiopulmonary Bypass in Obese Patients. Can Respir J 2018;2018:1039635. https://doi.org/10.1155/2018/1039635.

[277] Stéphan F, Bérard L, Rézaiguia-Delclaux S, Amaru P, BiPOP Study Group. High-Flow Nasal Cannula Therapy Versus Intermittent Noninvasive Ventilation in Obese Subjects After Cardiothoracic Surgery. Respir Care 2017;62:1193–202. https://doi.org/10.4187/respcare.05473.

[278] Ge Y, Li Z, Xia A, Liu J, Zhou D. Effect of high-flow nasal cannula versus non-invasive ventilation after extubation on successful extubation in obese patients: a retrospective analysis of the MIMIC-IV database. BMJ Open Respir Res 2023;10:e001737. https://doi.org/10.1136/bmjresp-2023-001737.

[279] Rochwerg B, Einav S, Chaudhuri D, Mancebo J, Mauri T, Helviz Y, et al. The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline. Intensive Care Med 2020;46:2226–37. https://doi.org/10.1007/s00134-020-06312-y.

[280] Thille AW, Coudroy R, Nay M-A, Gacouin A, Decavèle M, Sonneville R, et al. Beneficial Effects of Noninvasive Ventilation after Extubation in Obese or Overweight Patients: A Post Hoc Analysis of a Randomized Clinical Trial. Am J Respir Crit Care Med 2022;205:440–9. https://doi.org/10.1164/rccm.202106-1452OC.

[281] Jaber S, Chanques G, Jung B. Postoperative noninvasive ventilation. Anesthesiology 2010;112:453–61. https://doi.org/10.1097/ALN.0b013e3181c5e5f2.

[282] Jaber S, Lescot T, Futier E, Paugam-Burtz C, Seguin P, Ferrandiere M, et al. Effect of Noninvasive Ventilation on Tracheal Reintubation Among Patients With Hypoxemic Respiratory Failure Following Abdominal Surgery: A Randomized Clinical Trial. JAMA 2016;315:1345–53. https://doi.org/10.1001/jama.2016.2706.

[283] Bahammam AS, Al-Jawder SE. Managing acute respiratory decompensation in the morbidly obese. Respirology 2012;17:759–71. https://doi.org/10.1111/j.1440-1843.2011.02099.x.

[284] Carrillo A, Ferrer M, Gonzalez-Diaz G, Lopez-Martinez A, Llamas N, Alcazar M, et al. Noninvasive ventilation in acute hypercapnic respiratory failure caused by obesity hypoventilation syndrome and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186:1279–85. https://doi.org/10.1164/rccm.201206-1101OC.

[285] Lemyze M, Taufour P, Duhamel A, Temime J, Nigeon O, Vangrunderbeeck N, et al. Determinants of noninvasive ventilation success or failure in morbidly obese patients in acute respiratory failure. PLoS One 2014;9:e97563. https://doi.org/10.1371/journal.pone.0097563.

[286] Lemyze M, Granier M. Le patient obèse en insuffisance respiratoire aiguë, un défi pour la réanimation. Revue Des Maladies Respiratoires 2019;36:971–84. https://doi.org/10.1016/j.rmr.2018.10.621.

[287] Faria DAS, da Silva EMK, Atallah ÁN, Vital FMR. Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery. Cochrane Database Syst Rev 2015;2015:CD009134. https://doi.org/10.1002/14651858.CD009134.pub2.

[288] Pettenuzzo T, Boscolo A, Pistollato E, Pretto C, Giacon TA, Frasson S, et al. Effects of non-invasive respiratory support in post-operative patients: a systematic review and network meta-analysis. Crit Care 2024;28:152. https://doi.org/10.1186/s13054-024-04924-0.

[289] Leone M, Einav S, Chiumello D, Constantin J-M, De Robertis E, De Abreu MG, et al. Noninvasive respiratory support in the hypoxaemic peri-operative/periprocedural patient: a joint ESA/ESICM guideline. Intensive Care Med 2020;46:697–713. https://doi.org/10.1007/s00134-020-05948-0.

[290] Song H-Z, Gu J-X, Xiu H-Q, Cui W, Zhang G-S. The value of high-flow nasal cannula oxygen therapy after extubation in patients with acute respiratory failure. Clinics (Sao Paulo) 2017;72:562–7. https://doi.org/10.6061/clinics/2017(09)07.

[291] Fernandez R, Subira C, Frutos-Vivar F, Rialp G, Laborda C, Masclans JR, et al. High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial. Ann Intensive Care 2017;7:47. https://doi.org/10.1186/s13613-017-0270-9.

[292] Hernández G, Vaquero C, Colinas L, Cuena R, González P, Canabal A, et al. Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation on Reintubation and Postextubation Respiratory Failure in High-Risk Patients: A Randomized Clinical Trial. JAMA 2016;316:1565–74. https://doi.org/10.1001/jama.2016.14194.

[293] Esteban A, Frutos-Vivar F, Ferguson ND, Arabi Y, Apezteguía C, González M, et al. Noninvasive Positive-Pressure Ventilation for Respiratory Failure after Extubation. New England Journal of Medicine 2004;350:2452–60. https://doi.org/10.1056/NEJMoa032736.

[294] Jaber S, De Jong A, Castagnoli A, Futier E, Chanques G. Non-invasive ventilation after surgery. Ann Fr Anesth Reanim 2014;33:487–91. https://doi.org/10.1016/j.annfar.2014.07.742.

[295] De Jong A, Verzilli D, Jaber S. ARDS in Obese Patients: Specificities and Management. Crit Care 2019;23:74. https://doi.org/10.1186/s13054-019-2374-0.

[296] Yang MMH, Hartley RL, Leung AA, Ronksley PE, Jetté N, Casha S, et al. Preoperative predictors of poor acute postoperative pain control: a systematic review and meta-analysis. BMJ Open 2019;9:e025091. https://doi.org/10.1136/bmjopen-2018-025091.

[297] Kluger MT, Rice DA, Borotkanics R, Lewis GN, Somogyi AA, Barratt DT, et al. Factors associated with persistent opioid use 6-12 months after primary total knee arthroplasty. Anaesthesia 2022;77:882–91. https://doi.org/10.1111/anae.15783.

[298] Ding Y-Y, Yao P, Wu L, Han Z-K, Hong T, Zhu Y-Q, et al. Body mass index and persistent pain after breast cancer surgery: findings from the women’s healthy eating and living study and a meta-analysis. Oncotarget 2017;8:43332–43. https://doi.org/10.18632/oncotarget.17948.

[299] Lavoie-Gagne O, Nwachukwu BU, Allen AA, Leroux T, Lu Y, Forsythe B. Factors Predictive of Prolonged Postoperative Narcotic Usage Following Orthopaedic Surgery. JBJS Rev 2020;8:e0154. https://doi.org/10.2106/JBJS.RVW.19.00154.

[300] Torensma B, Thomassen I, van Velzen M, In ’t Veld BA. Pain Experience and Perception in the Obese Subject Systematic Review (Revised Version). Obes Surg 2016;26:631–9. https://doi.org/10.1007/s11695-015-2008-9.

[301] Gløersen M, Steen Pettersen P, Neogi T, Jafarzadeh SR, Vistnes M, Thudium CS, et al. Associations of Body Mass Index With Pain and the Mediating Role of Inflammatory Biomarkers in People With Hand Osteoarthritis. Arthritis Rheumatol 2022;74:810–7. https://doi.org/10.1002/art.42056.

[302] Zhang D-H, Fan Y-H, Zhang Y-Q, Cao H. Neuroendocrine and neuroimmune mechanisms underlying comorbidity of pain and obesity. Life Sci 2023;322:121669. https://doi.org/10.1016/j.lfs.2023.121669.

[303] Zhong Y, Tian K, Zhu Y, Li Y. Chronic Pain and Obesity in Community-Dwelling Adults: Findings from the National Health and Nutrition Examination Survey. J Pain Res 2024;17:3115–25. https://doi.org/10.2147/JPR.S470855.

[304] Zhao G, Ford ES, Dhingra S, Li C, Strine TW, Mokdad AH. Depression and anxiety among US adults: associations with body mass index. Int J Obes 2009;33:257–66. https://doi.org/10.1038/ijo.2008.268.

[305] Lewis GN, Rice DA, McNair PJ, Kluger M. Predictors of persistent pain after total knee arthroplasty: a systematic review and meta-analysis. Br J Anaesth 2015;114:551–61. https://doi.org/10.1093/bja/aeu441.

[306] Aceto P, Lai C, Perilli V, Sacco T, Modesti C, Raffaelli M, et al. Factors affecting acute pain perception and analgesics consumption in patients undergoing bariatric surgery. Physiol Behav 2016;163:1–6. https://doi.org/10.1016/j.physbeh.2016.04.032.

[307] Gupta K, Nagappa M, Prasad A, Abrahamyan L, Wong J, Weingarten TN, et al. Risk factors for opioid-induced respiratory depression in surgical patients: a systematic review and meta-analyses. BMJ Open 2018;8:e024086. https://doi.org/10.1136/bmjopen-2018-024086.

[308] Belcaid I, Eipe N. Perioperative Pain Management in Morbid Obesity. Drugs 2019;79:1163–75. https://doi.org/10.1007/s40265-019-01156-3.

[309] Stenberg E, dos Reis Falcão LF, O’Kane M, Liem R, Pournaras DJ, Salminen P, et al. Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update. World Journal of Surgery 2022;46:1. https://doi.org/10.1007/s00268-021-06394-9.

[310] Carron M, Tamburini E, Linassi F, Pettenuzzo T, Boscolo A, Navalesi P. Non-Opioid Analgesics and Adjuvants after Surgery in Adults with Obesity: Systematic Review with Network Meta-Analysis of Randomized Controlled Trials. J Clin Med 2024;13:2100. https://doi.org/10.3390/jcm13072100.

[311] Carron M, Tamburini E, Linassi F, Pettenuzzo T, Boscolo A, Navalesi P. Efficacy of nonopioid analgesics and adjuvants in multimodal analgesia for reducing postoperative opioid consumption and complications in obesity: a systematic review and network meta-analysis. British Journal of Anaesthesia 2024;133:1234–49. https://doi.org/10.1016/j.bja.2024.08.009.

[312] Albarrak AA. Safety of Non-steroidal Anti-inflammatory Drugs as Part of Enhanced Recovery After Laparoscopic Sleeve Gastrectomy-A Systematic Review and Meta-Analysis. Obes Surg 2024;34:643–52. https://doi.org/10.1007/s11695-023-06984-7.

[313] Skogar ML, Sundbom M. Nonsteroid anti-inflammatory drugs and the risk of peptic ulcers after gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis 2022;18:888–93. https://doi.org/10.1016/j.soard.2022.03.019.

[314] Wang J, Sun Y, Ai P, Cui V, Shi H, An D, et al. The effect of intravenous ketamine on depressive symptoms after surgery: A systematic review. J Clin Anesth 2022;77:110631. https://doi.org/10.1016/j.jclinane.2021.110631.

[315] Wang J, Echevarria GC, Doan L, Ekasumara N, Calvino S, Chae F, et al. Effects of a single subanaesthetic dose of ketamine on pain and mood after laparoscopic bariatric surgery: A randomised double-blind placebo controlled study. Eur J Anaesthesiol 2019;36:16–24. https://doi.org/10.1097/EJA.0000000000000860.

[316] Tian C, Malhan RS, Deng SX, Lee Y, Peachey J, Singh M, et al. Benefits of dexmedetomidine on postoperative analgesia after bariatric surgery. Minerva Anestesiol 2022;88:173–83. https://doi.org/10.23736/S0375-9393.21.15986-3.

[317] Hung K-C, Chiu C-C, Hsu C-W, Lin C-M, Liao S-W, Teng I-C, et al. Impact of Opioid-Free Anesthesia on Analgesia and Recovery Following Bariatric Surgery: a Meta-Analysis of Randomized Controlled Studies. Obes Surg 2022;32:3113–24. https://doi.org/10.1007/s11695-022-06213-7.

[318] Hung K-C, Chang Y-J, Chen I-W, Chang Y-P, Chiu S-F, Sun C-K. Efficacy of intraoperative intravenous lidocaine for postoperative analgesia following bariatric surgery: a meta-analysis of randomized controlled studies. Surg Obes Relat Dis 2022;18:135–47. https://doi.org/10.1016/j.soard.2021.08.014.

[319] Kizilcik N, Koner O. Magnesium Sulfate Reduced Opioid Consumption in Obese Patients Undergoing Sleeve Gastrectomy: a Prospective, Randomized Clinical Trial. Obes Surg 2018;28:2783–8. https://doi.org/10.1007/s11695-018-3243-7.

[320] Ao Y, Ma J, Zheng X, Zeng J, Wei K. Opioid-Sparing Anesthesia Versus Opioid-Free Anesthesia for the Prevention of Postoperative Nausea and Vomiting after Laparoscopic Bariatric Surgery: A Systematic Review and Network Meta-Analysis. Anesth Analg 2025;140:385–96. https://doi.org/10.1213/ANE.0000000000006942.

[321] Ulbing S, Infanger L, Fleischmann E, Prager G, Hamp T. The Performance of Opioid-Free Anesthesia for Bariatric Surgery in Clinical Practice. Obes Surg 2023;33:1687–93. https://doi.org/10.1007/s11695-023-06584-5.

[322] Clanet M, Touihri K, El Haddad C, Goldsztejn N, Himpens J, Fils JF, et al. Effect of opioid-free versus opioid-based strategies during multimodal anaesthesia on postoperative morphine consumption after bariatric surgery: a randomised double-blind clinical trial. BJA Open 2024;9:100263. https://doi.org/10.1016/j.bjao.2024.100263.

[323] Beaussier M, Delbos A, Maurice-Szamburski A, Ecoffey C, Mercadal L. Perioperative Use of Intravenous Lidocaine. Drugs 2018;78:1229–46. https://doi.org/10.1007/s40265-018-0955-x.

[324] Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Curr Opin Hematol 2013;20:437–44. https://doi.org/10.1097/MOH.0b013e3283634443.

[325] Parkin L, Sweetland S, Balkwill A, Green J, Reeves G, Beral V, et al. Body mass index, surgery, and risk of venous thromboembolism in middle-aged women: a cohort study. Circulation 2012;125:1897–904. https://doi.org/10.1161/CIRCULATIONAHA.111.063354.

[326] Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet J-P, et al. Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis. Eur Heart J 2018;39:1672–1686f. https://doi.org/10.1093/eurheartj/ehy066.

[327] Pahlkotter MK, Mohidul S, Moen MR, Digney BW, Holmes S, Muertos K, et al. BMI and VTE Risk in Emergency General Surgery, Does Size Matter? : An ACS-NSQIP Database Analysis. Am Surg 2020;86:1660–5. https://doi.org/10.1177/0003134820940272.

[328] Godier A, Lasne D, Pernod G, Blais N, Bonhomme F, Bounes F, et al. Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network. Anaesth Crit Care Pain Med 2024:101446. https://doi.org/10.1016/j.accpm.2024.101446.

[329] Winegar DA, Sherif B, Pate V, DeMaria EJ. Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2011;7:181–8. https://doi.org/10.1016/j.soard.2010.12.008.

[330] Almarshad FM, Almegren M, Alshuaibi T, Alobaodi N, Almutawa A, Basunbl H, et al. Thromboprophylaxis after bariatric surgery. Blood Res 2020;55:44–8. https://doi.org/10.5045/br.2020.55.1.44.

[331] Altawil E, Alkofide H, Almohaini H, Alobeed A, Alhossan A. The use of enoxaparin as venous thromboembolism prophylaxis in bariatric surgery: A retrospective cohort study. Saudi Pharm J 2022;30:1473–8. https://doi.org/10.1016/j.jsps.2022.07.008.

[332] Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, et al. To What Extent Does Posthospital Discharge Chemoprophylaxis Prevent Venous Thromboembolism After Bariatric Surgery?: Results From a Nationwide Cohort of More Than 110,000 Patients. Ann Surg 2018;267:727–33. https://doi.org/10.1097/SLA.0000000000002285.

[333] Altieri MS, Yang J, Hajagos J, Spaniolas K, Park J, Gasparis AP, et al. Evaluation of VTE prophylaxis and the impact of alternate regimens on post-operative bleeding and thrombotic complications following bariatric procedures. Surg Endosc 2018;32:4805–12. https://doi.org/10.1007/s00464-018-6231-z.

[334] Shao C, Xu K, Zhang L, Yu T, Yu N. Effect of body mass index on symptomatic venous thromboembolism and prosthesis revision risk after total knee arthroplasty: a long-term study from China. BMC Musculoskelet Disord 2022;23:676. https://doi.org/10.1186/s12891-022-05634-w.

[335] Thompson R, Cassidy R, Hill J, Bryce L, Napier R, Beverland D. Are Patients With Morbid Obesity at Increased Risk of Pulmonary Embolism or Proximal Deep Vein Thrombosis After Lower Limb Arthroplasty? A Large-database Study. Clin Orthop Relat Res 2024;482:115–24. https://doi.org/10.1097/CORR.0000000000002742.

[336] Kinder F, Giannoudis PV, Boddice T, Howard A. The Effect of an Abnormal BMI on Orthopaedic Trauma Patients: A Systematic Review and Meta-Analysis. J Clin Med 2020;9:1302. https://doi.org/10.3390/jcm9051302.

[337] Madsen HJ, Gillette RA, Colborn KL, Henderson WG, Dyas AR, Bronsert MR, et al. The association between obesity and postoperative outcomes in a broad surgical population: A 7-year American College of Surgeons National Surgical Quality Improvement analysis. Surgery 2023;173:1213–9. https://doi.org/10.1016/j.surg.2023.02.001.

[338] Abdelsalam AM, ElAnsary AMSE, Salman MA, Nassef SA, Elfergany HM, Aisha HAA. Adding a Preoperative Dose of LMWH may Decrease VTE Following Bariatric Surgery. World J Surg 2021;45:126–31. https://doi.org/10.1007/s00268-020-05782-x.

[339] Birkmeyer NJO, Finks JF, Carlin AM, Chengelis DL, Krause KR, Hawasli AA, et al. Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery. Arch Surg 2012;147:994–8. https://doi.org/10.1001/archsurg.2012.2298.

[340] Brunetti L, Wassef A, Sadek R, Deshpande K, Ziegler J, Na SS, et al. Anticoagulant activity of enoxaparin and unfractionated heparin for venous thromboembolism prophylaxis in obese patients undergoing sleeve gastrectomy. Surg Obes Relat Dis 2019;15:363–73. https://doi.org/10.1016/j.soard.2018.12.014.

[341] Gruel Y, De Maistre E, Pouplard C, Mullier F, Susen S, Roullet S, et al. Diagnosis and management of heparin-induced thrombocytopenia. Anaesth Crit Care Pain Med 2020;39:291–310. https://doi.org/10.1016/j.accpm.2020.03.012.

[342] Arcelus JI, Gouin-Thibault I, Samama CM. European guidelines on peri-operative venous thromboembolism prophylaxis: first update.: Chapter 10: Surgery in the obese patient. Eur J Anaesthesiol 2024;41:607–11. https://doi.org/10.1097/EJA.0000000000002000.

[343] Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 2002;12:19–24. https://doi.org/10.1381/096089202321144522.

[344] Wang T-F, Milligan PE, Wong CA, Deal EN, Thoelke MS, Gage BF. Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. Thromb Haemost 2014;111:88–93. https://doi.org/10.1160/TH13-01-0042.

[345] Amaral FC, Baptista-Silva JC, Nakano LC, Flumignan RL. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery. Cochrane Database Syst Rev 2022;11:CD013683. https://doi.org/10.1002/14651858.CD013683.pub2.

[346] Celik F, Huitema ADR, Hooijberg JH, van de Laar AWJM, Brandjes DPM, Gerdes VEA. Fixed-dose enoxaparin after bariatric surgery: the influence of body weight on peak anti-Xa levels. Obes Surg 2015;25:628–34. https://doi.org/10.1007/s11695-014-1435-3.

[347] Steib A, Degirmenci S-E, Junke E, Asehnoune K, Figier M, Pericard C, et al. Once versus twice daily injection of enoxaparin for thromboprophylaxis in bariatric surgery: effects on antifactor Xa activity and procoagulant microparticles. A randomized controlled study. Surgery for Obesity and Related Diseases 2016;12:613–21. https://doi.org/10.1016/j.soard.2015.08.505.

[348] Miranda S, Le Cam-Duchez V, Benichou J, Donnadieu N, Barbay V, Le Besnerais M, et al. Adjusted value of thromboprophylaxis in hospitalized obese patients: A comparative study of two regimens of enoxaparin: The ITOHENOX study. Thromb Res 2017;155:1–5. https://doi.org/10.1016/j.thromres.2017.04.011.

[349] Base de Données Publique des Médicaments n.d. https://base-donnees-publique.medicaments.gouv.fr/medicament/63108338/extrait#tab-notice (accessed November 17, 2025).

[350] Hainer JW, Barrett JS, Assaid CA, Fossler MJ, Cox DS, Leathers T, et al. Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study. Thromb Haemost 2002;87:817–23.

[351] Tseng EK, Kolesar E, Handa P, Douketis JD, Anvari M, Tiboni M, et al. Weight-adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery. J Thromb Haemost 2018;16:2008–15. https://doi.org/10.1111/jth.14263.

[352] Steele KE, Canner J, Prokopowicz G, Verde F, Beselman A, Wyse R, et al. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial. Surg Obes Relat Dis 2015;11:672–83. https://doi.org/10.1016/j.soard.2014.10.003.

[353] Martin KA, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S. Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation. J Thromb Haemost 2021;19:1874–82. https://doi.org/10.1111/jth.15358.

[354] Lott N, Robb F, Nolan E, Attia J, Reeves P, Gani J, et al. Efficacy of intermittent compression devices for thromboembolic prophylaxis in major abdominal surgery: a systematic review and meta-analysis. ANZ J Surg 2022;92:2926–34. https://doi.org/10.1111/ans.18101.

[355] Duval C, Sirois C, Savoie-White FH, Tardif P-A, Bérubé M, Turgeon AF, et al. Effect of Intermittent Pneumatic Compression in Addition to Pharmacologic Prophylaxis for Thromboprophylaxis in Hospitalized Adult Patients: A Systematic Review and Meta-Analysis. Crit Care Explor 2022;4:e0769. https://doi.org/10.1097/CCE.0000000000000769.

[356] Kakkos S, Kirkilesis G, Caprini JA, Geroulakos G, Nicolaides A, Stansby G, et al. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism. Cochrane Database Syst Rev 2022;1:CD005258. https://doi.org/10.1002/14651858.CD005258.pub4.

[357] Lobastov K, Sautina E, Alencheva E, Bargandzhiya A, Schastlivtsev I, Barinov V, et al. Intermittent Pneumatic Compression in Addition to Standard Prophylaxis of Postoperative Venous Thromboembolism in Extremely High-risk Patients (IPC SUPER): A Randomized Controlled Trial. Ann Surg 2021;274:63–9. https://doi.org/10.1097/SLA.0000000000004556.

[358] DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med 2007;356:2176–83. https://doi.org/10.1056/NEJMct067019.

[359] Chakravartty S, Sarma DR, Patel AG. Rhabdomyolysis in bariatric surgery: a systematic review. Obes Surg 2013;23:1333–40. https://doi.org/10.1007/s11695-013-0913-3.

[360] Chavez LO, Leon M, Einav S, Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care 2016;20:135. https://doi.org/10.1186/s13054-016-1314-5.

[361] Azran C, Wolk O, Zur M, Fine-Shamir N, Shaked G, Czeiger D, et al. Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations. Obes Rev 2016;17:1050–66. https://doi.org/10.1111/obr.12434.

[362] Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006;55:2025–31. https://doi.org/10.2337/db06-0068.

[363] Éléments d’appréciation en vue de la prise en charge d’un patient en chirurgie ambulatoire. Haute Autorité de Santé 2014. https://www.has-sante.fr/jcms/c_1346147/fr/elements-d-appreciation-en-vue-de-la-prise-en-charge-d-un-patient-en-chirurgie-ambulatoire (accessed December 22, 2025).

[364] Badaoui R, Rebibo L, Thiel V, Perret C, Popov I, Dhahri A, et al. [Observational study on outpatient sleeve gastrectomy]. Ann Fr Anesth Reanim 2014;33:497–502. https://doi.org/10.1016/j.annfar.2014.09.001.

[365] Rebibo L, Maurice KK, Nimier M, Ben Rehouma M, Montravers P, Msika S. Laparoscopic sleeve gastrectomy as day-case surgery: a review of the literature. Surg Obes Relat Dis 2019;15:1211–7. https://doi.org/10.1016/j.soard.2019.03.020.

[366] Lemanu DP, Singh PP, Berridge K, Burr M, Birch C, Babor R, et al. Randomized clinical trial of enhanced recovery versus standard care after laparoscopic sleeve gastrectomy. Br J Surg 2013;100:482–9. https://doi.org/10.1002/bjs.9026.

[367] Geubbels N, Evren I, Acherman YIZ, Bruin SC, van de Laar AWJM, Hoen MB, et al. Randomized clinical trial of an enhanced recovery after surgery programme versus conventional care in laparoscopic Roux-en-Y gastric bypass surgery. BJS Open 2019;3:274–81. https://doi.org/10.1002/bjs5.50143.

[368] Zhou B, Ji H, Liu Y, Chen Z, Zhang N, Cao X, et al. ERAS reduces postoperative hospital stay and complications after bariatric surgery: A retrospective cohort study. Medicine (Baltimore) 2021;100:e27831. https://doi.org/10.1097/MD.0000000000027831